Related Experiment Video
Updated: May 24, 2025

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish
Published on: April 16, 2019
Enhancing Blood-Brain Barrier Penetration Prediction by Machine Learning-Based Integration of Novel and Existing, In
Clemens P Spielvogel1,2, Natalie Schindler1, Christian Schröder3,4
1Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, 1090 Austria.
This study developed a novel machine learning (ML) model for predicting blood-brain barrier (BBB) penetration, outperforming existing methods. The ML approach enhances CNS drug development by improving accuracy and reducing experimental testing.
Area of Science:
- Medicinal Chemistry
- Computational Chemistry
- Pharmacology
Background:
- Predicting blood-brain barrier (BBB) penetration is critical for central nervous system (CNS) drug development, yet poses a significant challenge.
- Existing prediction models often lack standardization and geometric optimization, leading to calculation variations, particularly for polar surface area (PSA).
Purpose of the Study:
- To develop a novel machine learning (ML)-based scoring system for BBB penetration prediction.
- To create a standardized database and novel in silico 3D calculation for PSA.
- To evaluate and compare the performance of the ML model against existing prediction rules.
Main Methods:
- Developed a standardized dataset of 154 molecules with 24 molecular parameters, including experimental and in silico measurements.
- Implemented a novel in silico 3D calculation for nonclassical PSA.
- Trained and validated ML models using a 100-fold Monte Carlo cross-validation framework.
- Employed explainable artificial intelligence (AI) methods like Shapley additive explanations (SHAP) for parameter influence analysis.
Main Results:
- The ML random forest model achieved superior performance in predicting binary BBB penetration (AUC 0.88) and multiclass predictions (AUC 0.82).
- The ML approach significantly outperformed existing scores like CNS MPO (AUC 0.53) and BBB score (AUC 0.68).
- SHAP analysis confirmed the multifactorial nature of BBB penetration and the advantage of multivariate ML models.
Conclusions:
- The integrated ML approach enhances BBB penetration prediction accuracy by combining experimental and in silico data with novel methods.
- This approach can reduce reliance on extensive experimental measurements and animal testing, accelerating CNS drug development.
- The study highlights the potential of ML and explainable AI in optimizing drug discovery for CNS-related therapies.
More Related Videos
07:52A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain
Published on: April 9, 2019
09:53Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020